Manhal Izzy (@manhalizzy) 's Twitter Profile
Manhal Izzy

@manhalizzy

Director of TH Fellowship and Hep research @VUMC_Liver | Studying Cirrhotic Cardiomyopathy | @montefioreNYC & @mayoclinic alumnus. Tweets are my own.

ID: 1008923974871511041

calendar_today19-06-2018 04:06:35

633 Tweet

1,1K Followers

723 Following

Alexandra Shingina, M.D., M.Sc. (@ashinginamd) 's Twitter Profile Photo

📣📣#livertwitter ✅have a wealth of experience to share? ✅want to contribute to the rise of next generation of #liver Tx stars? ✅ are you over 10 years post training? ✍️Consider signing up for ILTS Mentorship program! Anjana Pillai Nazia Selzner kym watt Elliot Tapper

Manhal Izzy (@manhalizzy) 's Twitter Profile Photo

Thanks ILTS for a fantastic #LiverTransplant Congress!! A great meeting to see the latest developments in LT, catch up with colleagues & collaborators, and meet new ones. So wonderful to see Transplant Hepatology, Surgery, and Anesthesia under one ☂️ILTS

kym watt (@kymwatt) 's Twitter Profile Photo

Surveillance recs for all SOT recipients coming to transplant with a history of cancer. An amazing group of collaborators across transplant and oncology domains. Liver/Intestinal Community of Practice - AST AASLD ILTS

Manhal Izzy (@manhalizzy) 's Twitter Profile Photo

It’s so wonderful to see non liver non GI societies joining the campaign for raising awareness about MASH/MASLD! Kudos to Endocrine Society for taking it to next level and making the attendees hotel rooms key cover a beautiful illustration/reminder about checking FIB4 for these pts

It’s so wonderful to see non liver non GI societies joining the campaign for raising awareness about MASH/MASLD! Kudos to <a href="/TheEndoSociety/">Endocrine Society</a> for taking it to next level and making the attendees hotel rooms key cover a beautiful illustration/reminder about checking FIB4 for these pts
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

Newly released phase IIb 48-week liver biopsy data on #tirzepatide in #MASH. 73.9% resolution of MASH with no worsening of fibrosis on tirzepatide 15 mg. Secondary endpoint ⬇️ fibrosis by >1 stage with no worsening of MASH seen with all doses. #EASLCongress EASLnews EASL Education

Newly released phase IIb 48-week liver biopsy data on #tirzepatide in #MASH. 73.9% resolution of MASH with no worsening of fibrosis on tirzepatide 15 mg. Secondary endpoint ⬇️ fibrosis by &gt;1 stage with no worsening of MASH seen with all doses. #EASLCongress <a href="/EASLnews/">EASLnews</a> <a href="/EASLedu/">EASL Education</a>
Varia Kirchner (@kirchnervaria) 's Twitter Profile Photo

ILTS ILTS Vanguard Journal Club U of MN Radiology Manhal Izzy Rela Hospital StanfordAbdTxp Ryan Chadha ILTS Education & Scholarship and Vanguard Committees Collaboration! New Podcast by Prof. Siobhan Flanagan on IR techniques for intrahepatic malignancies. open.spotify.com/episode/35qDcj…

Valeria Mas, MSc,PhD, FAST (@valeriamas11) 's Twitter Profile Photo

The most amazing scientific program, state of the art speakers, summit liver research, innovative surgical technology, hands on workshops, join American Society of Transplantation (AST) ESOTtransplant AASLD ASTS @ElLITA_ELTR sessions in the magnificent Singapore! Alfred Kow Nazia Selzner

The most amazing scientific program, state of the art speakers, summit liver research, innovative surgical technology, hands on workshops, join <a href="/AST_info/">American Society of Transplantation (AST)</a> <a href="/ESOTtransplant/">ESOTtransplant</a> <a href="/AASLDtweets/">AASLD</a> <a href="/ASTSChimera/">ASTS</a> @ElLITA_ELTR sessions in the magnificent Singapore! <a href="/alfredkow/">Alfred Kow</a> <a href="/NaziaSelzner/">Nazia Selzner</a>
Ed Livingston (@ehljama) 's Twitter Profile Photo

DO GLP-1 Agonists Really Cause Eye Disease There has been a huge amount of press about a report showing an association between the use of GLP-1 agonists and Nonarteritic anterior ischemic optic neuropathy (NAION) jamanetwork.com/journals/jamao… Because of it being heavily promoted by

DO GLP-1 Agonists Really Cause Eye Disease

There has been a huge amount of press about a report showing an association between the use of GLP-1 agonists and Nonarteritic anterior ischemic optic neuropathy (NAION)

jamanetwork.com/journals/jamao…

Because of it being heavily promoted by
Manhal Izzy (@manhalizzy) 's Twitter Profile Photo

Congrats Ashley Spann and thanks for making us proud!!! We’re so happy for you. I must say that the only thing that can make a mentor happier than their own success is their mentees’ success. #ProudMentor

Juan Pablo (JP) Arab, MD  (@juanpabloarab) 's Twitter Profile Photo

I am very grateful to have been able to collaborate in this The Lancet Seminar on Acute Liver Failure with Rakhi Maiwall Anand V Kulkarni Salvatore Piano Very important topic, hope you find it useful and informative 👉 Acute liver failure (ALF) is a life-threatening disorder

I am very grateful to have been able to collaborate in this <a href="/TheLancet/">The Lancet</a> Seminar on Acute Liver Failure with <a href="/MaiwallRakhi/">Rakhi Maiwall</a> <a href="/AnandVKulkarni2/">Anand V Kulkarni</a> <a href="/salvatore_piano/">Salvatore Piano</a> 
Very important topic, hope you find it useful and informative
👉 Acute liver failure (ALF) is a life-threatening disorder
Ashley Spann (@ashleyspannmd) 's Twitter Profile Photo

Excited for this work to get out there on how we can use #informatics in #livertransplant! Special thanks to Jeremy Louissaint Manhal Izzy for helping get this over the finish line and into Liver Transplantation Journal (LTxJournal) journals.lww.com/lt/abstract/99…

Excited for this work to get out there on how we can use #informatics in #livertransplant! Special thanks to <a href="/jlouissaint89/">Jeremy Louissaint</a> <a href="/manhalizzy/">Manhal Izzy</a> for helping get this over the finish line and into <a href="/LTxJournal/">Liver Transplantation Journal (LTxJournal)</a> journals.lww.com/lt/abstract/99…
M PREMKUMAR (@docmpk) 's Twitter Profile Photo

pubmed.ncbi.nlm.nih.gov/39181168/ 💥 Recompensation in 24.7% 24.7% of 1152 HCV related cirrhosis patients following SVR-12, portal hypertension progressed in 13.7% and 2.9% had a new development of HCC over 48 months follow-up. Data from Punjab, India 🇮🇳 Radha K Dhiman